Tiffany A. Traina, MD; Vijayakrishna Gadi, MD, PhD, and Heather McArthur, MD, underscore the importance of testing all early-stage and breast cancer patients for HER2 positivity to inform and guide optimal therapeutic decision-making.

Related Keywords

Vijayakrishna Gadi , Tiffanya Traina , Heather Mcarthur , , Treatment Approach , Positive Breast Cancer , Breast Cancer , Treatment Goals , Metastatic Breast Cancer ,